Cargando…
Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer
While there is no reliable serum biomarker for the diagnosis and monitoring of patients with gastric cancer, we tested the potential diagnostic and prognostic values of detecting methylation changes in the serum of gastric cancer patients. DNA was extracted from the pretherapeutic serum of 60 patien...
Autores principales: | Leung, W K, To, K-F, Chu, E S H, Chan, M W Y, Bai, A H C, Ng, E K W, Chan, F K L, Sung, J J Y |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361805/ https://www.ncbi.nlm.nih.gov/pubmed/15942635 http://dx.doi.org/10.1038/sj.bjc.6602636 |
Ejemplares similares
-
The prognostic value of CDKN2A hypermethylation in colorectal cancer: a meta-analysis
por: Xing, X, et al.
Publicado: (2013) -
Somatostatin Receptor 1, a novel EBV-associated CpG hypermethylated gene, contributes to the pathogenesis of EBV-associated gastric cancer
por: Zhao, J, et al.
Publicado: (2013) -
Identification of retinoic acid-regulated nuclear matrix-associated protein as a novel regulator of gastric cancer
por: Li, J, et al.
Publicado: (2009) -
Serum biomarker panels for the diagnosis of gastric adenocarcinoma
por: Ahn, H S, et al.
Publicado: (2012) -
Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line
por: To, K F, et al.
Publicado: (2004)